Patents by Inventor Edward D. Purich

Edward D. Purich has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11744878
    Abstract: The invention relates generally to methods for treating and modulating the severity of COVID-19 syndrome. The methods comprise administering a therapeutically effective amount of a pharmaceutical composition to a human patient, the composition comprising secretin and a pharmaceutically acceptable carrier.
    Type: Grant
    Filed: July 30, 2021
    Date of Patent: September 5, 2023
    Assignee: CHIRHOCLIN, INC.
    Inventor: Edward D. Purich
  • Publication number: 20220362213
    Abstract: This invention relates generally to methods of treating post-endoscopic retrograde cholangiopancreatography pancreatitis. The method comprises sublingually or buccally administering to a patient deemed to be at risk of developing post endoscopic retrograde cholangiopancreatography pancreatitis prior to undergoing endoscopic retrograde cholangiopancreatography (ERCP), a therapeutically effective amount of a pharmaceutical composition comprising indomethacin or diclofenac or a combination thereof and a pharmaceutically acceptable carrier.
    Type: Application
    Filed: May 9, 2022
    Publication date: November 17, 2022
    Inventors: Edward E. Purich, Edward D. Purich
  • Publication number: 20220054592
    Abstract: The invention relates generally to methods for treating and modulating the severity of COVID-19 syndrome. The methods comprise administering a therapeutically effective amount of a pharmaceutical composition to a human patient, the composition comprising secretin and a pharmaceutically acceptable carrier.
    Type: Application
    Filed: July 30, 2021
    Publication date: February 24, 2022
    Inventor: Edward D. Purich
  • Patent number: 9962430
    Abstract: The invention relates generally to methods for treating pain associated with chronic pancreatitis in patients. The methods comprise administering a therapeutically effective amount of a pharmaceutical composition comprising secretin and a pharmaceutically acceptable carrier.
    Type: Grant
    Filed: February 13, 2013
    Date of Patent: May 8, 2018
    Assignee: CHIRHOCLIN, INC.
    Inventor: Edward D. Purich
  • Publication number: 20140349939
    Abstract: The invention relates generally to methods for treating pain associated with chronic pancreatitis in patients. The methods comprise administering a therapeutically effective amount of a pharmaceutical composition comprising secretin and a pharmaceutically acceptable carrier.
    Type: Application
    Filed: February 13, 2013
    Publication date: November 27, 2014
    Inventor: Edward D. Purich
  • Patent number: 7947285
    Abstract: The invention relates generally to methods for preventing post endoscopic retrograde cholangiopancreatography pancreatitis (ERCP). The method comprises administering a therapeutically effective amount of a pharmaceutical composition comprising secretin and a pharmaceutically acceptable carrier.
    Type: Grant
    Filed: May 16, 2005
    Date of Patent: May 24, 2011
    Inventors: Seymour H. Fein, Edward D. Purich, Paul S. Jowell, John Baillie
  • Patent number: 7381698
    Abstract: The invention relates generally to methods for treating acute pancreatitis in patients. The methods comprise administering a therapeutically effective amount of a pharmaceutical composition comprising secretin and a pharmaceutically acceptable carrier.
    Type: Grant
    Filed: December 8, 2004
    Date of Patent: June 3, 2008
    Assignee: ChiRhoClin, Inc.
    Inventors: Seymour H. Fein, Edward D. Purich